U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Showing 1 - 10 of 106 results

ZINC CATION

MORE DETAILS

  13S1S8SF37

Status:
US Approved OTC
First marketed in 1921
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
Methotrexate
38
respiratory burst
39
Streptococcus mutans
41
transformed cell apoptotic process
104
ultraviolet B-induced damage
38
T cell mediated immunity
40
Zinc transporter ZIP1
38
Zinc transporter ZIP2
38
Conditions:
Renal insufficiency
40
Ulcerative colitis
125
Unknown
2,596
Caries
43
Breast cancer
432
Acute myeloid leukemia
141
Zinc deficiency
39
Poison Ivy dermatitis
38
Diaper dermatitis
38
Unknown
2,596
Dysgeusia
38
Mucositis
39
Gastrointestinal disorders
94
Unknown
2,596
Unknown
2,596
There is no available information related any biological and pharmaceutical application of ammonium tetrachlorozincate.

MAGNESIUM CATION

MORE DETAILS

  T6V3LHY838

Status:
US Approved OTC
First marketed in 1921
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
magnesium ion homeostasis
70
action potential
66
Protein S100-A8
66
magnesium ion homeostasis
70
magnesium ion homeostasis
70
oxalate metabolic process
66
magnesium ion homeostasis
70
Conditions:
Magnesium deficiency
67
Unknown
2,596
Unknown
2,596
Eclampsia
69
Preeclampsia
85
Preparation for colonoscopy
66
Atrial fibrillation
131
Unknown
2,596
Unknown
2,596
Stroke
144
Magnesium deficiency
67
Fibromyalgia
90
Magnesium deficiency
67
Convulsions
72
Eclampsia
69
Oxaluria
66
Constipation
112
Magnesium deficiency
67
Unknown
2,596
Unknown
2,596
Magnesium deficiency
67
Unknown
2,596
Bone disease
70
Bacterial infections
235
Bronchial spasm
78
Unknown
2,596
Magnesium diamide is used as a chemical intermediate. Magnesium diamide is spontaneously combustible. It is toxic by inhalation. Skin or eye contact may cause severe burns.

SENECIALDEHYDE

MORE DETAILS

2JZ2B60W76

Status:
Other
Class (Stereo):
CHEMICAL (ACHIRAL)

P-ANISALDEHYDE

MORE DETAILS

9PA5V6656V

Status:
Possibly Marketed Outside US
First approved in 2017
Class (Stereo):
CHEMICAL (ACHIRAL)

MAGNESIUM LACTATE

MORE DETAILS

  MT6QI8324A

Status:
US Approved OTC
First marketed in 1921
Class (Stereo):
CHEMICAL (RACEMIC)
Targets:
magnesium ion homeostasis
70
action potential
66
Protein S100-A8
66
magnesium ion homeostasis
70
magnesium ion homeostasis
70
oxalate metabolic process
66
magnesium ion homeostasis
70
Conditions:
Magnesium deficiency
67
Unknown
2,596
Unknown
2,596
Eclampsia
69
Preeclampsia
85
Preparation for colonoscopy
66
Atrial fibrillation
131
Unknown
2,596
Unknown
2,596
Stroke
144
Magnesium deficiency
67
Fibromyalgia
90
Magnesium deficiency
67
Convulsions
72
Eclampsia
69
Oxaluria
66
Constipation
112
Magnesium deficiency
67
Unknown
2,596
Unknown
2,596
Magnesium deficiency
67
Unknown
2,596
Bone disease
70
Bacterial infections
235
Bronchial spasm
78
Unknown
2,596
Magnesium diamide is used as a chemical intermediate. Magnesium diamide is spontaneously combustible. It is toxic by inhalation. Skin or eye contact may cause severe burns.

ZINC DIBUTYRATE

MORE DETAILS

  VA6XH8E3JX

Status:
US Approved OTC
First marketed in 1921
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
Methotrexate
38
respiratory burst
39
Streptococcus mutans
41
transformed cell apoptotic process
104
ultraviolet B-induced damage
38
T cell mediated immunity
40
Zinc transporter ZIP1
38
Zinc transporter ZIP2
38
Conditions:
Renal insufficiency
40
Ulcerative colitis
125
Unknown
2,596
Caries
43
Breast cancer
432
Acute myeloid leukemia
141
Zinc deficiency
39
Poison Ivy dermatitis
38
Diaper dermatitis
38
Unknown
2,596
Dysgeusia
38
Mucositis
39
Gastrointestinal disorders
94
Unknown
2,596
Unknown
2,596
There is no available information related any biological and pharmaceutical application of ammonium tetrachlorozincate.

ALMADRATE SULFATE

MORE DETAILS

  9104833TPA

Status:
US Approved OTC
First marketed in 1921
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
magnesium ion homeostasis
70
action potential
66
Protein S100-A8
66
magnesium ion homeostasis
70
magnesium ion homeostasis
70
oxalate metabolic process
66
magnesium ion homeostasis
70
Conditions:
Magnesium deficiency
67
Unknown
2,596
Unknown
2,596
Eclampsia
69
Preeclampsia
85
Preparation for colonoscopy
66
Atrial fibrillation
131
Unknown
2,596
Unknown
2,596
Stroke
144
Magnesium deficiency
67
Fibromyalgia
90
Magnesium deficiency
67
Convulsions
72
Eclampsia
69
Oxaluria
66
Constipation
112
Magnesium deficiency
67
Unknown
2,596
Unknown
2,596
Magnesium deficiency
67
Unknown
2,596
Bone disease
70
Bacterial infections
235
Bronchial spasm
78
Unknown
2,596
Magnesium diamide is used as a chemical intermediate. Magnesium diamide is spontaneously combustible. It is toxic by inhalation. Skin or eye contact may cause severe burns.

ZINC CITRATE DIHYDRATE

MORE DETAILS

  021IBV57IL

Status:
US Approved OTC
First marketed in 1921
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
Methotrexate
38
respiratory burst
39
Streptococcus mutans
41
transformed cell apoptotic process
104
ultraviolet B-induced damage
38
T cell mediated immunity
40
Zinc transporter ZIP1
38
Zinc transporter ZIP2
38
Conditions:
Renal insufficiency
40
Ulcerative colitis
125
Unknown
2,596
Caries
43
Breast cancer
432
Acute myeloid leukemia
141
Zinc deficiency
39
Poison Ivy dermatitis
38
Diaper dermatitis
38
Unknown
2,596
Dysgeusia
38
Mucositis
39
Gastrointestinal disorders
94
Unknown
2,596
Unknown
2,596
There is no available information related any biological and pharmaceutical application of ammonium tetrachlorozincate.

MAGNESIUM OXOGLURATE

MORE DETAILS

  4B6P4CLD8W

Status:
US Approved OTC
First marketed in 1921
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
magnesium ion homeostasis
70
action potential
66
Protein S100-A8
66
magnesium ion homeostasis
70
magnesium ion homeostasis
70
oxalate metabolic process
66
magnesium ion homeostasis
70
Conditions:
Magnesium deficiency
67
Unknown
2,596
Unknown
2,596
Eclampsia
69
Preeclampsia
85
Preparation for colonoscopy
66
Atrial fibrillation
131
Unknown
2,596
Unknown
2,596
Stroke
144
Magnesium deficiency
67
Fibromyalgia
90
Magnesium deficiency
67
Convulsions
72
Eclampsia
69
Oxaluria
66
Constipation
112
Magnesium deficiency
67
Unknown
2,596
Unknown
2,596
Magnesium deficiency
67
Unknown
2,596
Bone disease
70
Bacterial infections
235
Bronchial spasm
78
Unknown
2,596
Magnesium diamide is used as a chemical intermediate. Magnesium diamide is spontaneously combustible. It is toxic by inhalation. Skin or eye contact may cause severe burns.

MAGNESIUM SULFATE TRIHYDRATE

MORE DETAILS

  25DG81L0KE

Status:
US Approved OTC
First marketed in 1921
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
magnesium ion homeostasis
70
action potential
66
Protein S100-A8
66
magnesium ion homeostasis
70
magnesium ion homeostasis
70
oxalate metabolic process
66
magnesium ion homeostasis
70
Conditions:
Magnesium deficiency
67
Unknown
2,596
Unknown
2,596
Eclampsia
69
Preeclampsia
85
Preparation for colonoscopy
66
Atrial fibrillation
131
Unknown
2,596
Unknown
2,596
Stroke
144
Magnesium deficiency
67
Fibromyalgia
90
Magnesium deficiency
67
Convulsions
72
Eclampsia
69
Oxaluria
66
Constipation
112
Magnesium deficiency
67
Unknown
2,596
Unknown
2,596
Magnesium deficiency
67
Unknown
2,596
Bone disease
70
Bacterial infections
235
Bronchial spasm
78
Unknown
2,596
Magnesium diamide is used as a chemical intermediate. Magnesium diamide is spontaneously combustible. It is toxic by inhalation. Skin or eye contact may cause severe burns.
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966